April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Talazoparib in Combination With Enzalutamide for Prostate Cancer – FDA Oncology
Mar 15, 2024, 18:07

Talazoparib in Combination With Enzalutamide for Prostate Cancer – FDA Oncology

FDA Oncology posted on X/Twitter:

FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer – Journal of Clinical Oncology. 1st author Brian Heiss, last author Daniel Suzman.

Image

View additional information.
Source: FDA Oncology/X